New and updated preclinical and clinical data presented by biopharma firms at the American Association for Cancer Research annual meeting, including: Akeso, Ascentage, Astellas, Biosion, Cstone, Innovent, Inventisbio, Pharmabcine, Pyxis, Qihan, Seagen.

New and updated preclinical and clinical data presented by biopharma firms at the American Association for Cancer Research annual meeting, including: Antengene, Coherus, Junshi.

Computational technology and high-quality data will help scientists to improve R&D and find better treatments for human diseases, according to experts at the Wuxi Global Forum 2022.

Data presented at the American Society of Hematology annual meeting, including: Antengene, Aptose, Ascentage, Beigene, Daiichi Sankyo, Hutchmed, I-Mab, Iaso, Innocare, Innovent, JW, Tessa.

Data presented at the American Society of Hematology annual meeting, including: Beigene, Carsgen, Samsung Bioepis, Tessa.

Data presented at the Society for Immunotherapy of Cancer annual meeting – Nov. 10-14, including: Immutep.

Data presented at the Society for Immunotherapy of Cancer annual meeting – Nov. 10-14, including: Antengene.

Plants could be an alternative vaccine platform for both COVID-19 and future pandemics, shaking up a biologics sector that is currently mostly protein-based. South Korean company Bioapplications Inc., for example, is aiming to have a plant-derived booster shot for COVID-19 in the clinic in 2022.